![](/img/cover-not-exists.png)
Randomized, double-blind, placebo-controlled trial of the oral interleukin-12/23 inhibitor apilimod mesylate for treatment of active Crohn's disease
Bruce E. Sands, Eric W. Jacobson, Thomas Sylwestrowicz, Ziad Younes, Gerald Dryden, Richard Fedorak, Susan GreenbloomVolume:
16
Year:
2010
Language:
english
Pages:
1
DOI:
10.1002/ibd.21159
File:
PDF, 349 KB
english, 2010